Angiodynamics (ANGO) Cash from Investing Activities (2010 - 2026)

Angiodynamics (ANGO) has 17 years of Cash from Investing Activities data on file, last reported at -$1.5 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Investing Activities rose 52.74% year-over-year to -$1.5 million; the trailing twelve-month figure through Feb 2026 stood at -$7.3 million (up 26.18% YoY), and the FY2025 full-year result was -$10.2 million, down 108.23% from the prior year.
• Cash from Investing Activities for Q1 2026 stood at -$1.5 million, up from -$1.6 million in the prior quarter.
• Across five years, Cash from Investing Activities topped out at $98.4 million in Q3 2023 and bottomed at -$3.8 million in Q2 2022.
• The 5-year median for Cash from Investing Activities is -$2.1 million (2023), against an average of $5.5 million.
• The widest annual swing landed in 2023, when Cash from Investing Activities jumped 2852.85%; it then plunged 110.85% in 2025.
• A 5-year view of Cash from Investing Activities shows it stood at -$2.5 million in 2022, then climbed by 28.17% to -$1.8 million in 2023, then decreased by 9.37% to -$2.0 million in 2024, then climbed by 17.34% to -$1.6 million in 2025, then gained by 7.03% to -$1.5 million in 2026.
• The last three Cash from Investing Activities figures came in at -$1.5 million (Q1 2026), -$1.6 million (Q4 2025), and -$1.6 million (Q3 2025), per Business Quant data.

Peer Comparison